We share
our knowledge

We share our knowledge

Scientific
publications

A novel platform for attenuating immune hyperactivity using EXO-CD24 in COVID-19 and beyond

A novel platform for attenuating immune hyperactivity using EXO-CD24 in COVID-19 and beyond

A novel platform for attenuating immune hyperactivity using EXO-CD24 in COVID-19 and beyond

A novel platform for attenuating immune hyperactivity using EXO-CD24 in COVID-19 and beyond

Media coverage

Interest grows in three experimental COVID-19 treatments

"Magični metak" - lek koji Srbija planira da nabavi u borbi protiv kovida

Israeli drug holds promise of stopping fatal Covid-19 immune response

El medicamento 'de Fierabrás' israelí que curaría el covid en 5 días

A fin de año estaría en uso revolucionario remedio israelí para Covid-19

O tratamento israelita que promete revolucionar o combate à covid-19

Lek iz Izraela navodno zaustavlja kovid za pet dana

COVID: 90% of patients treated with new Israeli drug discharged in 5 days

Media coverage

logoA
"Magični metak" - lek koji Srbija planira da nabavi u borbi protiv kovida
logoD
Interest grows in three experimental COVID-19 treatments
mena
Israeli drug holds promise of stopping fatal Covid-19 immune response
Elmundo
El medicamento 'de Fierabrás' israelí que curaría el covid en 5 días
סמנר
A fin de año estaría en uso revolucionario remedio israelí para Covid-19
דיאריו
O tratamento israelita que promete revolucionar o combate à covid-19
N
Lek iz Izraela navodno zaustavlja kovid za pet dana
jpost-logo
COVID: 90% of patients treated with new Israeli drug discharged in 5 days

Other resources